AMA announces new CPT code for Johnson & Johnson’s COVID-19 vaccine
In preparation of a pending vaccine approval, the AMA recently added a new CPT code that will be used to report a COVID-19 vaccine candidate under development by Janssen Pharmaceuticals, a division of Johnson & Johnson.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.